Pique Therapeutics
Durham, US · North Carolina corporation
Founders & leadership
KD
Keith DionneNamed on SEC filing
CM
Christopher MeldrumNamed on SEC filing
JB
John B. BrennanNamed on SEC filing
IJ
Ian J. MehrAssistant Secretary
Reported raises · per SEC filings
Form D private placements$854.1K disclosed across 1 round · 2017
▶$854.1KraisedDec 2018 · 13 investors · Biotechnology
▶$854.1KraisedDec 2018 · 13 investors · Biotechnology
Officers, directors & promoters on the filing
- Keith DionneDirector
- Ian J. MehrExecutive Officer
- Christopher MeldrumExecutive Officer, Director
- John B. BrennanDirector
- Offering amount
- $1000K
- Amount sold
- $854.1K
- Minimum investment
- $5K
- First sale
- Jul 2017
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Pique Therapeutics raised?
- Pique Therapeutics has disclosed $854.1K raised across 1 round.
- Where is Pique Therapeutics headquartered?
- Pique Therapeutics is headquartered in Durham, US.